Article

Pharmacy Times: Week of February 22 Lineup

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:

  • A video interview with J. David Robertson, the director of University of Missouri Research Reactor (MURR), on how a new collaboration between MURR and Advanced Accelerator Applications International will help to develop a targeted therapy for certain types of cancerous tumors.
  • An article from the recent Society for Advancing Business Editing and Writing Healthcare 2021 virtual symposium, which discusses the main challenges surrounding COVID-19 vaccination—increasing vaccine production and delivery. The presentation noted that the faster people are vaccinated, the fewer opportunities there will be for variant versions of COVID-19 to spread and for more variants to emerge.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com